Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · DuoTrav

DuoTrav 40 micrograms/mL + 5 mg/mL eye drops, solution · Abschnitt 4.8 · PDF-Seite 9

HOS-208573 · Präparat HOS-154129

System organ class MedDRA preferred term Immune system disorders Seasonal allergy Psychiatric disorders Anxiety, insomnia Eye disorders Uveitis, conjunctival follicles, eye discharge, periorbital oedema, eyelids pruritus, ectropion, cataract, iridocyclitis, ophthalmic herpes simplex, eye inflammation, photopsia, eczema eyelids, halo vision, hypoaesthesia eye, anterior chamber pigmentation, mydriasis, eyelash hyperpigmentation, eyelash thickening, visual field defect Ear and labyrinth disorders Vertigo, tinnitus Vascular disorders Blood pressure diastolic decreased, blood pressure systolic increased Respiratory, thoracic and mediastinal disorders Asthma aggravated, rhinitis allergic, epistaxis, respiratory disorder, nasal congestion, nasal dryness Gastrointestinal disorders Peptic ulcer reactivated, gastrointestinal disorder, diarrhoea, constipation, dry mouth, abdominal pain, nausea, vomiting Skin and subcutaneous tissue disorders Skin exfoliation, hair texture abnormal, dermatitis allergic, hair colour changes, madarosis, pruritus, hair growth abnormal, erythema Musculoskeletal and connective tissue disorders Musculoskeletal pain, arthralgia Renal and urinary disorders Dysuria, urinary incontinence General disorders and administration site Asthenia conditions Investigations Prostatic specific antigen increased

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.